XML 30 R19.htm IDEA: XBRL DOCUMENT
v3.26.1

SEGMENT INFORMATION | 3 Months Ended
--- | ---
Mar. 31, 2026
Segment Reporting [Abstract] |
SEGMENT INFORMATION | NOTE 11 – SEGMENT INFORMATION Operating segments are defined as components of an entity for which separate financial information is available and that is regularly provided to the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources to an individual segment and in assessing performance. The Company conducted the business through two primary operating segments: NanoVibronix and ENvue. NanoVibronix derives revenues from selling its products directly to patients as well as through distributor agreements. ENvue derives revenues from selling its systems and nasoenteral tubes. Non-allocated administrative and other expenses are reflected in Corporate. The Company’s Chief Executive Officer is the Company’s CODM. The CODM reviews financial information presented by operating segment in making operating decisions, allocating resources, and evaluating financial performance. The CODM allocates resources to and assesses the performance of each operating segment using information about the operating segment’s loss from operations. SCHEDULE OF SEGMENT INFORMATION Goodwill and Assets
|  | NanoVibronix |  |  | ENvue |  |  | Corporate |  |  | Total |
Balance sheet at March 31, 2026 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Goodwill |  | $ | - |  |  | $ | 29,082 |  |  | $ | - |  |  | $ | 29,082 |
Assets |  | $ | 2,482 |  |  | $ | 37,389 |  |  | $ | - |  |  | $ | 39,871 |
Balance sheet at December 31, 2025 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Goodwill |  | $ | - |  |  | $ | 29,082 |  |  | $ | - |  |  | $ | 29,082 |
Assets |  | $ | 1,924 |  |  | $ | 39,200 |  |  | $ | - |  |  | $ | 41,124 |
Segment operating results
Three Months Ended 31, 2026: |  | NanoVibronix |  |  | ENvue |  |  | Corporate |  |  | Total |
Revenues |  | $ | 534 |  |  | $ | 119 |  |  | $ | - |  |  | $ | 653 |
Cost of revenues |  |  | 389 |  |  |  | 319 |  |  |  | - |  |  |  | 708 |
Research and development |  |  | 40 |  |  |  | 428 |  |  |  | - |  |  |  | 468 |
Selling and marketing |  |  | 279 |  |  |  | 493 |  |  |  | - |  |  |  | 772 |
General and administrative |  |  | 380 |  |  |  | 643 |  |  |  | 1,393 |  |  |  | 2,416 |
Impairment expense |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Total operating loss |  | $ | (554 | ) |  | $ | (1,764 | ) |  | $ | (1,393 | ) |  | $ | (3,711 | )
Three Months Ended 31, 2025: |  | NanoVibronix |  |  | ENvue |  |  | Corporate |  |  | Total |
Revenues |  | $ | 922 |  |  | $ | 103 |  |  | $ | - |  |  | $ | 1,025 |
Cost of revenues |  |  | 590 |  |  |  | 66 |  |  |  | - |  |  |  | 656 |
Research and development |  |  | 412 |  |  |  | 118 |  |  |  | - |  |  |  | 530 |
Selling and marketing |  |  | 146 |  |  |  | 203 |  |  |  | - |  |  |  | 349 |
General and administrative |  |  | 386 |  |  |  | 157 |  |  |  | 799 |  |  |  | 1,342 |
Total operating loss |  | $ | (612 | ) |  | $ | (441 | ) |  | $ | (799 | ) |  | $ | (1,852 | )
ENVUE MEDICAL, INC. Notes to the Interim Condensed Consolidated Financial Statements (unaudited) (Amounts in thousands except share and per share data) Geographic Information and Major Customer Data The following is a summary of revenues within geographic areas: SUMMARY OF REVENUE WITHIN GEOGRAPHIC AREAS
|  | Three Months Ended March 31 |
|  | 2026 |  |  | 2025 |
United States |  | $ | 490 |  |  | $ | 986 |
Europe |  |  | 163 |  |  |  | 9 |
Other |  |  | - |  |  |  | 30 |
Total |  | $ | 653 |  |  | $ | 1,025 |
Major Customer Data as a Percentage of Total Revenues The following is a summary of revenues: SCHEDULE OF PERCENTAGE OF TOTAL REVENUES
|  | Three Months Ended March 31, |
|  | 2026 |  |  | 2025 |
Customer A |  |  | 27 | % |  |  | 49 | %
Customer B |  |  | 25 | % |  |  | 1 | %
Customer C |  |  | 14 | % |  |  | 18 | %
Total |  |  | 66 | % |  |  | 68 | %

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for segment reporting. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 34 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (ee) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26C -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 15: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 48 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 270 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1 Reference 17: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 18: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 19: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 20: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 21: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 22: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/280/tableOfContent Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration